Administrative & Regulatory

Administrative agencies and changes in the area of regulatory law, are two areas of law which are regularly covered in the news media. And, because these areas of law change frequently, it is important to have the latest news which is available. The National Law Review covers the latest administrative and regulatory actions as they unfold. From appointment of new Administrative law judges (ALJs), to the appointment of the Officer of Management and Budget office in Mick Mulvaney, the National Law Review covers this, and other agency and regulatory news as it unfolds.

New regulations in tax-law, rulemaking decisions, the Securities and Exchange Commission (SEC), and the latest news in regulatory agendas, are reported on daily on NLR’s website. The adjudication and enforcement of regulatory agendas, new appointments to government offices and agencies, and news from the federal and state-level, is updated on the National Law Review daily. Readers can find information about new legislation, law-making, changes in government agencies, the appointment of new directors, and litigation involving administrative and regulatory news as it unfolds.

Anything encompassing new government regulations will also be found under the administrative and regulatory law section on The National Law Review. Regulations made by government agencies via the powers appointed to them by statutes or the Constitution are highly covered topics on the National Law Review as well. For visitors who want the latest information on the new administration which is heading the CFPB, to reading about new state regulations where they live, will find such topics covered on NLR.

Because news is unfolding on a regular basis, visitors want to read about the latest topics, areas of concern, and rulemaking which might affect them in the future. The National Law Review adds new content on a daily basis, meaning visitors will always have up-to-date legal analysis on regulations that may impact their business.

 

For hourly updates on the latest in legal, legislation, government regulation, and corporate law news, be sure to follow the National Law Review Twitter feed, and sign up for complimentary e-news bulletins.

 

Custom text Title Sort descending Organization
Jul
13
2020
FDA Announces Plans for Resuming On-Site Domestic Inspections of Food Facilities Keller and Heckman LLP
Jul
13
2020
FDA Announces Plans to Resume Domestic On-site Inspections Sheppard, Mullin, Richter & Hampton LLP
Dec
12
2011
FDA Announces Proposals for Biosimilars User Fees and Performance Review Goals Sheppard, Mullin, Richter & Hampton LLP
Feb
1
2023
FDA Announces Proposed Redesign to Create Human Foods Program Keller and Heckman LLP
Apr
3
2019
FDA Announces Public Hearing on Products Containing Cannabis or Cannabis-Derived Compounds McDermott Will & Emery
Apr
26
2023
FDA Announces Public Meeting on Good Manufacturing Practices for Cosmetic Products Keller and Heckman LLP
Sep
18
2019
FDA Announces Public Meeting to Discuss “A New Era of Smarter Food Safety” Keller and Heckman LLP
Apr
12
2019
FDA Announces Public Meeting to Solicit Comments on Regulation of Dietary Supplements Keller and Heckman LLP
Jul
23
2020
FDA Announces Qualified Health Claim for Certain Cranberry Products and Urinary Tract Infections Keller and Heckman LLP
Feb
3
2023
FDA Announces Qualified Health Claim for Cocoa Flavanols in High Flavanol Cocoa Powder and Reduced Risk of Cardiovascular Disease Keller and Heckman LLP
Mar
1
2024
FDA Announces Qualified Health Claim for Yogurt and Reduced Risk of Type 2 Diabetes Keller and Heckman LLP
Sep
7
2022
FDA Announces Review of Opioid Prescribing Regulations and Framework for Preventing Overdose-Related Deaths Mintz
Sep
7
2022
FDA Announces Review of Opioid Prescribing Regulations and Framework for Preventing Overdose-Related Deaths Mintz
Jan
31
2022
FDA Announces Second Webinar in Series on Food Safety Culture Keller and Heckman LLP
Jul
21
2020
FDA Announces that Inspections of Small Businesses to Verify Compliance with the Intentional Adulteration Rule Will Begin March 2021 Keller and Heckman LLP
Oct
5
2020
FDA Announces Three Dates for Public Meetings to Discuss the Proposed Rule for Additional Traceability Records for Certain Foods Keller and Heckman LLP
Feb
7
2024
FDA Announces Update to Fruit Pouch Contamination Investigation Keller and Heckman LLP
Dec
21
2023
FDA Announces Updated Instructions for Serious Adverse Event Reporting for Cosmetic Products ArentFox Schiff LLP
Oct
22
2021
FDA Announces Withdrawal of Temporary Guidance Documents Concerning Alcohol-Based Hand Sanitizer Products Bergeson & Campbell, P.C.
May
1
2019
FDA Announces “New Era of Smarter Food Safety” Keller and Heckman LLP
Feb
9
2021
FDA Appointment Signals Increased Attention on Medical Device Cybersecurity Sheppard, Mullin, Richter & Hampton LLP
Jan
20
2023
FDA Approval Mifepristone REMS Program Modification Expands Patient Access to Abortion Care Sheppard, Mullin, Richter & Hampton LLP
Jan
17
2024
FDA Approves Florida Importing Drugs from Canada Greenberg Traurig, LLP
Oct
5
2021
FDA Approves New Blue Color Additive Keller and Heckman LLP
Jul
14
2022
FDA Approves Six Accreditation Bodies Under LAAF Keller and Heckman LLP
Feb
28
2023
FDA Asked to Allow “Healthy” Claims on Coffee Keller and Heckman LLP
Jul
6
2020
FDA Asks OMB to Approve Certain Information Collection Techniques to Support Further Research into Consumer Behavior Regarding Food and Other Areas Keller and Heckman LLP
May
5
2022
FDA Authorizes NJOY ACE Tobacco-Flavored Electronic Nicotine Delivery System (ENDS) Products for Marketing Keller and Heckman LLP
Jun
4
2021
FDA Ban On PFAS In Food Packaging Brought To Forefront CMBG3 Law
Oct
14
2021
FDA Begins Modernizing its Resources and Implementing Over-The-Counter Monograph User Fee Requirements Mintz
Jul
30
2018
FDA Begins Process of Modernizing Standards of Identity with Focus on Use of the Term “Milk” in Labeling Plant-Based Products Keller and Heckman LLP
Sep
1
2022
FDA Begins Third Phase of AI Seafood Program Keller and Heckman LLP
Feb
17
2022
FDA Boosts Protein Preemption Defense Sheppard, Mullin, Richter & Hampton LLP
Oct
26
2021
FDA Calls for Repeating Clinical and Bioanalytical Studies Foley & Lardner LLP
Jul
24
2019
FDA CBD Docket Closed, Agency to Soon Provide Status Report McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins